OrganiGram Historical Income Statement

OGI Stock

CAD 2.22 0.03 1.37%

Historical analysis of OrganiGram Holdings income statement accounts such as Total Operating Expenses of 335.5 M can show how well OrganiGram Holdings performed in making a profits. Evaluating OrganiGram Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of OrganiGram Holdings's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining OrganiGram Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OrganiGram Holdings is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.

About OrganiGram Income Statement Analysis

OrganiGram Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to OrganiGram Holdings shareholders. The income statement also shows OrganiGram investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

OrganiGram Holdings Income Statement Chart

At this time, OrganiGram Holdings' Cost Of Revenue is very stable compared to the past year. As of the 17th of January 2025, Total Other Income Expense Net is likely to grow to about 11.8 M, while Interest Expense is likely to drop about 303.5 K.

Selling General Administrative Other Operating Expenses Total Operating Expenses Selling And Marketing Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of OrganiGram Holdings. It is also known as OrganiGram Holdings overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from OrganiGram Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.At this time, OrganiGram Holdings' Cost Of Revenue is very stable compared to the past year. As of the 17th of January 2025, Total Other Income Expense Net is likely to grow to about 11.8 M, while Interest Expense is likely to drop about 303.5 K.

OrganiGram Holdings income statement Correlations

	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Income Before Tax	Depreciation And Amortization	Selling And Marketing Expenses	Total Revenue	Gross Profit	Cost Of Revenue	Total Other Income Expense Net	Net Interest Income	Interest Income	Discontinued Operations	Net Income From Continuing Ops	Reconciled Depreciation	Research Development
Interest Expense		0.0	-0.16	0.24	0.22	0.24	-0.22	0.18	0.3	0.19	-0.03	0.24	-0.05	0.15	-0.12	-0.33	-1.0	-0.1	-0.61	-0.19	-0.03	-0.3
Selling General Administrative	0.0		0.96	-0.87	-0.85	-0.82	0.89	-0.87	-0.43	-0.86	0.94	0.9	1.0	0.41	0.91	0.47	0.03	0.95	0.2	-0.28	0.88	0.91
Other Operating Expenses	-0.16	0.96		-0.95	-0.93	-0.92	0.97	-0.94	-0.52	-0.93	0.88	0.78	0.95	0.39	0.87	0.49	0.18	0.9	0.22	-0.19	0.8	0.97
Operating Income	0.24	-0.87	-0.95		0.99	0.99	-0.92	0.99	0.67	0.99	-0.82	-0.75	-0.86	-0.18	-0.87	-0.4	-0.25	-0.8	-0.32	0.32	-0.79	-0.91
Ebit	0.22	-0.85	-0.93	0.99		1.0	-0.89	1.0	0.65	1.0	-0.83	-0.74	-0.83	-0.12	-0.86	-0.29	-0.24	-0.8	-0.32	0.38	-0.8	-0.88
Ebitda	0.24	-0.82	-0.92	0.99	1.0		-0.9	0.99	0.66	1.0	-0.78	-0.69	-0.8	-0.12	-0.83	-0.29	-0.26	-0.76	-0.32	0.34	-0.75	-0.88
Total Operating Expenses	-0.22	0.89	0.97	-0.92	-0.89	-0.9		-0.9	-0.43	-0.89	0.77	0.67	0.89	0.51	0.74	0.51	0.24	0.84	0.19	0.01	0.69	0.99
Net Income	0.18	-0.87	-0.94	0.99	1.0	0.99	-0.9		0.62	1.0	-0.84	-0.76	-0.84	-0.15	-0.86	-0.27	-0.19	-0.81	-0.29	0.38	-0.81	-0.88
Income Tax Expense	0.3	-0.43	-0.52	0.67	0.65	0.66	-0.43	0.62		0.64	-0.4	-0.39	-0.44	0.42	-0.68	-0.4	-0.31	-0.24	-0.49	0.5	-0.39	-0.41
Income Before Tax	0.19	-0.86	-0.93	0.99	1.0	1.0	-0.89	1.0	0.64		-0.84	-0.75	-0.84	-0.13	-0.86	-0.28	-0.2	-0.8	-0.3	0.39	-0.8	-0.88
Depreciation And Amortization	-0.03	0.94	0.88	-0.82	-0.83	-0.78	0.77	-0.84	-0.4	-0.84		0.89	0.93	0.19	0.93	0.27	0.05	0.96	0.23	-0.5	0.96	0.81
Selling And Marketing Expenses	0.24	0.9	0.78	-0.75	-0.74	-0.69	0.67	-0.76	-0.39	-0.75	0.89		0.88	0.25	0.86	0.29	-0.21	0.83	0.13	-0.47	0.93	0.68
Total Revenue	-0.05	1.0	0.95	-0.86	-0.83	-0.8	0.89	-0.84	-0.44	-0.84	0.93	0.88		0.42	0.91	0.53	0.07	0.94	0.25	-0.24	0.87	0.91
Gross Profit	0.15	0.41	0.39	-0.18	-0.12	-0.12	0.51	-0.15	0.42	-0.13	0.19	0.25	0.42		0.0	0.45	-0.15	0.43	-0.34	0.68	0.13	0.49
Cost Of Revenue	-0.12	0.91	0.87	-0.87	-0.86	-0.83	0.74	-0.86	-0.68	-0.86	0.93	0.86	0.91	0.0		0.38	0.15	0.84	0.43	-0.58	0.9	0.77
Total Other Income Expense Net	-0.33	0.47	0.49	-0.4	-0.29	-0.29	0.51	-0.27	-0.4	-0.28	0.27	0.29	0.53	0.45	0.38		0.35	0.35	0.14	0.37	0.22	0.54
Net Interest Income	-1.0	0.03	0.18	-0.25	-0.24	-0.26	0.24	-0.19	-0.31	-0.2	0.05	-0.21	0.07	-0.15	0.15	0.35		0.12	0.61	0.18	0.05	0.32
Interest Income	-0.1	0.95	0.9	-0.8	-0.8	-0.76	0.84	-0.81	-0.24	-0.8	0.96	0.83	0.94	0.43	0.84	0.35	0.12		0.14	-0.25	0.91	0.89
Discontinued Operations	-0.61	0.2	0.22	-0.32	-0.32	-0.32	0.19	-0.29	-0.49	-0.3	0.23	0.13	0.25	-0.34	0.43	0.14	0.61	0.14		-0.27	0.24	0.21
Net Income From Continuing Ops	-0.19	-0.28	-0.19	0.32	0.38	0.34	0.01	0.38	0.5	0.39	-0.5	-0.47	-0.24	0.68	-0.58	0.37	0.18	-0.25	-0.27		-0.54	-0.01
Reconciled Depreciation	-0.03	0.88	0.8	-0.79	-0.8	-0.75	0.69	-0.81	-0.39	-0.8	0.96	0.93	0.87	0.13	0.9	0.22	0.05	0.91	0.24	-0.54		0.74
Research Development	-0.3	0.91	0.97	-0.91	-0.88	-0.88	0.99	-0.88	-0.41	-0.88	0.81	0.68	0.91	0.49	0.77	0.54	0.32	0.89	0.21	-0.01	0.74

Click cells to compare fundamentals

OrganiGram Holdings Account Relationship Matchups

OrganiGram Holdings income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	6.0M	3.0M	429K	277.8K	319.5K	303.5K
Selling General Administrative	29.9M	30.7M	42.4M	49.0M	56.3M	59.1M
Other Operating Expenses	184.7M	152.0M	184.6M	391.9M	450.7M	473.3M
Operating Income	(145.5M)	(91.8M)	(38.8M)	(242.7M)	(218.5M)	(207.5M)
Ebit	(139.4M)	(126.6M)	(12.6M)	(231.8M)	(208.6M)	(198.2M)
Ebitda	(121.5M)	(95.6M)	12.3M	(207.6M)	(186.9M)	(177.5M)
Total Operating Expenses	41.4M	44.4M	70.3M	277.8M	319.5M	335.5M
Net Income	(136.2M)	(132.5M)	(14.3M)	(229.5M)	(206.5M)	(196.2M)
Income Tax Expense	(10.5M)	1.8M	(88K)	(3.5M)	(3.2M)	(3.0M)
Income Before Tax	(146.6M)	(130.7M)	(14.4M)	(233.0M)	(209.7M)	(199.2M)
Depreciation And Amortization	18.0M	31.0M	24.9M	24.2M	27.8M	29.2M
Selling And Marketing Expenses	16.5M	15.8M	16.9M	17.9M	20.5M	10.3M
Total Revenue	86.8M	79.2M	145.8M	149.2M	171.6M	180.2M
Gross Profit	(56.5M)	(28.4M)	31.6M	35.1M	40.3M	42.4M
Cost Of Revenue	143.3M	107.6M	114.2M	114.1M	131.3M	137.8M
Total Other Income Expense Net	(1.1M)	(38.9M)	28.8M	9.7M	11.2M	11.8M
Net Income Applicable To Common Shares	(9.5M)	(136.2M)	(130.7M)	(14.3M)	(12.9M)	(13.5M)
Net Interest Income	(9.7M)	(6.0M)	(3.0M)	(429K)	(386.1K)	(405.4K)
Interest Income	10.3M	6.9M	33.1M	32.3M	37.2M	39.1M
Net Income From Continuing Ops	(9.5M)	(136.2M)	(130.7M)	(14.3M)	(12.9M)	(13.5M)
Reconciled Depreciation	8.9M	18.0M	31.0M	24.9M	28.6M	16.1M
Research Development	1.3M	3.5M	6.0M	12.2M	14.0M	14.7M

Pair Trading with OrganiGram Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OrganiGram Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against OrganiGram Stock

0.76	LMN	Lumine Group	Pair Corr
0.75	ATD	Alimentation Couchen Tard	Pair Corr
0.75	IAG	iA Financial	Pair Corr
0.71	CRM	SalesforceCom CDR	Pair Corr
0.67	CVO	Coveo Solutions	Pair Corr

The ability to find closely correlated positions to OrganiGram Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OrganiGram Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OrganiGram Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OrganiGram Holdings to buy it.

The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OrganiGram Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OrganiGram Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for OrganiGram Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:

How To Invest In OrganiGram

Details

Is OrganiGram Stock a good investment?

Details

What is OrganiGram Holdings' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

OrganiGram Historical Income Statement

About OrganiGram Income Statement Analysis

OrganiGram Holdings Income Statement Chart

Other Operating Expenses

Total Operating Expenses

OrganiGram Holdings income statement Correlations

OrganiGram Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

OrganiGram Holdings income statement Accounts

Pair Trading with OrganiGram Holdings

Moving against OrganiGram Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Income Before Tax	+ 1.0	Net Income

Net Interest Income	- 1.0	Interest Expense
Operating Income	- 0.95	Other Operating Expenses
Net Income	- 0.94	Other Operating Expenses
Income Before Tax	- 0.93	Other Operating Expenses
Ebit	- 0.93	Other Operating Expenses
Total Operating Expenses	- 0.92	Operating Income